Hannu Päivä

High-dose statins and skeletal muscle metabolism in humans: A randomized, controlled trial

Hannu Päivä, Karin Thelen, Rudy N. Van Coster et al. · Clinical Pharmacology & Therapeutics · 2005 · 307 citations

A Systems Biology Strategy Reveals Biological Pathways and Plasma Biomarker Candidates for Potentially Toxic Statin-Induced Changes in Muscle

Reijo Laaksonen, Mikko Katajamaa, Hannu Päivä et al. · PLoS ONE · 2006 · 222 citations · Full text

Decreased Skeletal Muscle Mitochondrial DNA in Patients Treated with High-Dose Simvastatin

Brian A. Schick, Reijo Laaksonen, Jiří Fröhlich et al. · Clinical Pharmacology & Therapeutics · 2007 · 101 citations

Plasma concentrations of asymmetric-dimethyl-arginine in type 2 diabetes associate with glycemic control and glomerular filtration rate but not with risk factors of vasculopathy

Hannu Päivä, Terho Lehtimäki, Juha Laakso et al. · Metabolism · 2003 · 84 citations

Plasma Concentrations, Metabolic Syndrome, Diabetes Management +14

Effect of High-Dose Statin Treatment on Plasma Concentrations of Endogenous Nitric Oxide Synthase Inhibitors

Hannu Päivä, Juha Laakso, Terho Lehtimäki et al. · Journal of Cardiovascular Pharmacology · 2003 · 78 citations

Hypertension, Hyperlipidemia, Pharmacotherapy +16